<\/span><\/h2>\nCBD has been studied for its potential therapeutic benefits in treating addiction to various substances. While research is still in the early stages, some studies suggest that CBD may have therapeutic properties for opioid, cocaine, and psychostimulant addiction, as well as cannabis and tobacco addiction in humans [1].<\/p>\n
A systematic review of preclinical studies on CBD as an intervention for addictive behaviors found that CBD may have a positive impact on drug-seeking behaviors associated with addiction [2]. In one study, CBD reduced the rewarding effects of morphine and reduced drug-seeking behavior in rats [3].<\/p>\n
CBD may also be effective in reducing withdrawal symptoms associated with addiction. In a study of individuals with heroin use disorder, CBD reduced anxiety and cravings associated with withdrawal, as well as levels of cortisol, a hormone associated with stress [4].<\/p>\n
It is important to note that while CBD shows promise as a potential treatment for addiction, more research is needed to fully understand its therapeutic potential and the optimal dosage and administration methods for different types of addiction.<\/p>\n
Overall, the current evidence suggests that CBD may have therapeutic potential for addiction treatment, but more research is needed to fully understand its effects.<\/p>\n
[1] Sholler, D. J., Schoene, L., & Spindle, T. R. (2020). Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies. Current Addiction Reports, 7(3), 405-412.<\/p>\n
[2] Prud'homme, M., Cata, R., & Jutras-Aswad, D. (2015). Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Substance Abuse: Research and Treatment, 9(S1), 33-38.<\/p>\n
[3] Ren, Y., Whittard, J., Higuera-Matas, A., Morris, C. V., & Hurd, Y. L. (2009). Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. Journal of Neuroscience, 29(47), 14764-14769.<\/p>\n
[4] Hurd, Y. L., Yoon, M., Manini, A. F., Hernandez, S., Olmedo, R., Ostman, M., & Jutras-Aswad, D. (2015). Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage. Neurotherapeutics, 12(4), 807-815.<\/p>\n